Risks of Myocarditis and Pericarditis Following Vaccination with SARS-CoV-2 mRNA Vaccines in Japan: An Analysis of Spontaneous Reports of Suspected Adverse Events

Objective To identify the risks of myocarditis or pericarditis after vaccination with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccines in Japan. Methods We conducted an observed-to-expected analysis (OE analysis) of spontaneous reports of suspected adverse events from pharm...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Therapeutic innovation & regulatory science 2023-03, Vol.57 (2), p.329-342
Hauptverfasser:	Kobayashi, Hidetaka, Fukuda, Sayoko, Matsukawa, Rina, Asakura, Yumi, Kanno, Yuri, Hatta, Tomohiro, Saito, Yurina, Shimizu, Yuki, Kawarasaki, Shuichi, Kihara, Mari, Kinoshita, Natsumi, Umeda, Hikari, Noda, Tatsuya, Imamura, Tomoaki, Nishioka, Yuichi, Yamaguchi, Toshihiro, Hayashi, Shuichiro, Iguchi, Toyotaka
Format:	Artikel
Sprache:	eng
Schlagworte:	2019-nCoV Vaccine mRNA-1273 Adolescent Adolescents Adverse events BNT162 Vaccine Coronaviruses COVID-19 COVID-19 Vaccines Drug Safety and Pharmacovigilance Heart diseases Humans Immunization Japan Male Males Medicine mRNA mRNA Vaccines Myocarditis Original Research Pandemics Pericarditis Pharmacotherapy Pharmacy SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Vaccination Vaccines Viral diseases Young Adult Young adults
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!